In this special report, PharmaLive.com and Med Ad News editors present the top 15 Japanese pharmaceutical company pipelines. The top companies are determined based on healthcare revenue generated during 2007.
The report details the following for each product: chemical or substance composition, intended indication, pipeline status, region of development, and developer/marketer.
All phases of clinical development have been considered for this special report — preclinical, Phase I, Phase II, Phase III and awaiting approval. This report concentrates on prescription products in development in Japan, Europe and the United States.
New to this report! Financial data including revenue, R&D, net income/loss, earnings per share, return on revenue, total assets, shareholders’ equity, number of employees, business segments, and year established.